RESUMO
Effort invested in the development of new drugs often fails to be translated into meaningful clinical benefits for patients with cancer. The development of more effective anticancer therapeutics and accurate prediction of their clinical merit remain urgent unmet medical needs. As solid cancers have complex and heterogeneous structures composed of different cell types and extracellular matrices, three-dimensional (3D) cancer models hold great potential for advancing our understanding of cancer biology, which has been historically investigated in tumour cell cultures on rigid plastic plates. Advanced 3D bioprinted cancer models have the potential to revolutionize the way we discover therapeutic targets, develop new drugs and personalize anticancer therapies in an accurate, reproducible, clinically translatable and robust manner. These ex vivo cancer models are already replacing existing in vitro systems and could, in the future, diminish or even replace the use of animal models. Therefore, profound understanding of the differences in tumorigenesis between 2D, 3D and animal models of cancer is essential. This Review presents the state of the art of 3D bioprinted cancer modelling, focusing on the biological processes that underlie the molecular mechanisms involved in cancer progression and treatment response as well as on proteomic and genomic signatures.
Assuntos
Neoplasias , Proteômica , Animais , Humanos , Neoplasias/tratamento farmacológico , Desenvolvimento de MedicamentosRESUMO
Many drugs show promising results in laboratory research but eventually fail clinical trials. We hypothesize that one main reason for this translational gap is that current cancer models are inadequate. Most models lack the tumor-stroma interactions, which are essential for proper representation of cancer complexed biology. Therefore, we recapitulated the tumor heterogenic microenvironment by creating fibrin glioblastoma bioink consisting of patient-derived glioblastoma cells, astrocytes, and microglia. In addition, perfusable blood vessels were created using a sacrificial bioink coated with brain pericytes and endothelial cells. We observed similar growth curves, drug response, and genetic signature of glioblastoma cells grown in our 3D-bioink platform and in orthotopic cancer mouse models as opposed to 2D culture on rigid plastic plates. Our 3D-bioprinted model could be the basis for potentially replacing cell cultures and animal models as a powerful platform for rapid, reproducible, and robust target discovery; personalized therapy screening; and drug development.
Assuntos
Glioblastoma , Animais , Astrócitos , Células Endoteliais , Glioblastoma/patologia , Humanos , Camundongos , Pericitos , Microambiente TumoralRESUMO
The complexity and diversity of the biochemical processes that occur during tumorigenesis and metastasis are frequently over-simplified in the traditional in vitro cell cultures. Two-dimensional cultures limit researchers' experimental observations and frequently give rise to misleading and contradictory results. Therefore, in order to overcome the limitations of in vitro studies and bridge the translational gap to in vivo applications, 3D models of cancer were developed in the last decades. The three dimensions of the tumor, including its cellular and extracellular microenvironment, are recreated by combining co-cultures of cancer and stromal cells in 3D hydrogel-based growth factors-inclusive scaffolds. More complex 3D cultures, containing functional blood vasculature, can integrate in the system external stimuli (e.g. oxygen and nutrient deprivation, cytokines, growth factors) along with drugs, or other therapeutic compounds. In this scenario, cell signaling pathways, metastatic cascade steps, cell differentiation and self-renewal, tumor-microenvironment interactions, and precision and personalized medicine, are among the wide range of biological applications that can be studied. Here, we discuss a broad variety of strategies exploited by scientists to create in vitro 3D cancer models that resemble as much as possible the biology and patho-physiology of in vivo tumors and predict faithfully the treatment outcome.
Assuntos
Nanomedicina/métodos , Alicerces Teciduais , Células Tumorais Cultivadas/patologia , Animais , Antineoplásicos/uso terapêutico , Humanos , Hidrogéis , Neoplasias/tratamento farmacológico , Neoplasias/patologia , Neoplasias/terapia , Esferoides Celulares/patologia , Células Tumorais Cultivadas/efeitos dos fármacosRESUMO
Pectin-chitosan hydrogels are intriguing and relatively new type of physically crosslinked hydrogels. Here we present for the first time a study exploring the suitability of pectin-chitosan hydrogels to serve as drug carriers and the mechanism controlling the release patterns. Using drug release assays, we demonstrated sustained release of three model drugs (mesalamine, curcumin and progesterone) over a period of 24h in physiological conditions. Fourier transform infrared spectroscopy (FTIR) and differential scanning calorimetry (DSC) experiments were used to characterize the interactions between the investigated drugs and the polymers. These experiments, as well as swelling analysis, support the claim that the magnitude of interactions strongly affect the release rates. These new pectin-chitosan thermoreversible hydrogels may improve the life style of many patients by reducing the daily uptake of chronic medicines.
Assuntos
Quitosana/química , Portadores de Fármacos/química , Hidrogéis/química , Pectinas/química , Portadores de Fármacos/metabolismo , Liberação Controlada de Fármacos , Mucosa Gástrica/metabolismo , Hidrogéis/metabolismo , Concentração OsmolarRESUMO
A new design for nanocomposite hydrogels based on cross-linked chitosan for the delivery of mesalamine is presented. To enhance drug loading in chitosan, the mineral montmorillonite was incorporated into the matrix. The exfoliated silica montmorillonite nanosheets form interactions with both chitosan and mesalamine, which affect the hydrogel's drug release mechanism and swelling properties. The impact of montmorillonite and glutaraldehyde concentrations on the hydrogel properties was investigated. In vitro drug-release studies detected slower release over short times when montmorillonite was introduced into the matrix. This study is the first to evaluate the influence of pH during mixing and on mixing duration. It was shown that lowering the pH during mixing delayed the release since the positively charged drug was better introduced between the montmorillonite layers, as confirmed by differential scanning calorimetry (DSC) and fourier transform infrared spectroscopy (FTIR) analysis. All hydrogels showed prolonged sustained release of mesalamine over 24h in simulated colonic fluid (pH 7.4). When modeled, the mesalamine release profile suggests a complex release mechanism, involving adsorption of the drug to the montmorillonite and its diffusion. The results imply that chitosan-montmorillonite hydrogels can serve as potential drug carriers for controlled-release applications.
Assuntos
Anti-Inflamatórios não Esteroides/administração & dosagem , Materiais Biocompatíveis , Hidrogéis/química , Mesalamina/administração & dosagem , Bentonita , Química Farmacêutica , Reagentes de Ligações Cruzadas , Portadores de Fármacos , Sistemas de Liberação de Medicamentos , Desenho de Fármacos , Concentração de Íons de Hidrogênio , Peso Molecular , Nanoestruturas , Tamanho da PartículaRESUMO
The use of injectable porous hydrogels is of great interest in biomedical applications due to their excellent permeability and ease of integration into sites of surgical intervention. By implementing a method that enables the formation in situ of pores with controllable porosity and pore size, it is possible to synthesize bioactive hydrogels that are tailor-made for specific biomedical applications. An emulsion-templating technique was used to encapsulate oil droplets, which are subsequently leached out of the hydrogel to create the porous structure. Pore size and porosity were manipulated by changing oil-to-water ratios and the surfactant concentrations. Highly swellable porous hydrogels were obtained with control over mechanical strength and diffusive properties. The relationship between porosity, pore size, and the hydrogel's physical and mechanical characteristics was analyzed, and the potential of this material as a protein drug delivery system was demonstrated.